Efficacy and safety of yokukansan in treatment-resistant schizophrenia: a randomized, double-blind, placebo-controlled trial (a Positive and Negative Syndrome Scale, five-factor analysis)
Crossref DOI link: https://doi.org/10.1007/s00213-014-3645-8
Published Online: 2014-06-13
Published Print: 2015-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Miyaoka, Tsuyoshi
Furuya, Motohide
Horiguchi, Jun
Wake, Rei
Hashioka, Sadayuki
Tohyama, Masaya
Mori, Norio
Minabe, Yoshio
Iyo, Masaomi
Ueno, Shyuichi
Ezoe, Sachiko
Murotani, Kenta
Hoshino, Syuzo
Seno, Haruo
Text and Data Mining valid from 2014-06-13